Why Gethin Prefers a Trickle Dose Over NAD IVs
Gethin rejects high-dose NAD IVs in favor of smaller oral or subcutaneous doses spread over time. He argues that the body can assimilate only so much at once and raises a potential cancer concern for people with genetic or family risk, though the episode does not substantiate the medical claim.
- Gethin prefers an oral multi-ingredient product for convenience
- He compares a large IV dose to eating a week's protein at once
- He recommends smaller doses distributed over time
- He cautions against high-dose NAD for people with possible cancer predisposition
“So, I'm not into NAD IVs, and I'll tell you why. I prefer like a trickle dose.”
“Not only that, we know that NAD can feed cancer. Can not not will. It can like if you've got a genetic disposition for cancer…”